GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Spire Healthcare Group PLC (LSE:SPI) » Definitions » 3-Year Revenue Growth Rate

Spire Healthcare Group (LSE:SPI) 3-Year Revenue Growth Rate : 12.70% (As of Jun. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Spire Healthcare Group 3-Year Revenue Growth Rate?

Spire Healthcare Group's Revenue per Share for the six months ended in Jun. 2024 was £1.84.

During the past 12 months, Spire Healthcare Group's average Revenue per Share Growth Rate was 12.20% per year. During the past 3 years, the average Revenue per Share Growth Rate was 12.70% per year. During the past 5 years, the average Revenue per Share Growth Rate was 7.40% per year. During the past 10 years, the average Revenue per Share Growth Rate was 3.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Spire Healthcare Group was 17.00% per year. The lowest was -4.80% per year. And the median was 6.05% per year.


Competitive Comparison of Spire Healthcare Group's 3-Year Revenue Growth Rate

For the Medical Care Facilities subindustry, Spire Healthcare Group's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Spire Healthcare Group's 3-Year Revenue Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Spire Healthcare Group's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Spire Healthcare Group's 3-Year Revenue Growth Rate falls into.



Spire Healthcare Group 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Spire Healthcare Group  (LSE:SPI) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Spire Healthcare Group 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Spire Healthcare Group's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Spire Healthcare Group Business Description

Traded in Other Exchanges
Address
3 Dorset Rise, London, GBR, EC4Y 8EN
Spire Healthcare Group PLC is an independent hospital group in the United Kingdom, with 40 private hospitals and eight clinics. It is a private provider, by volume, of knee and hip operations in the United Kingdom. The Group is a well-located and scalable hospital that has delivered successful and award-winning clinical outcomes, positioning the Group well with patients, Consultants, the NHS, GPs, and Private Medical Insurance providers. It treats patients through a variety of routes including PMI, Self-pay and the NHS, providing the Group with diversified access to the expected growth opportunities in the UK healthcare market, which faces significant supply challenges as a result of NHS budget constraints and increasing demand from a growing population with longer life expectancy.